Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.770
+0.070 (1.89%)
Aug 1, 2025, 3:58 PM CET
Accolade Market Cap
Arctic Bioscience AS has a market cap or net worth of 101.26 million as of August 1, 2025. Its market cap has decreased by -60.48% in one year.
Market Cap
101.26M
Enterprise Value
119.69M
Revenue
44.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.77
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 101.26M, a decrease of -84.85%. That is a compound annual growth rate of -34.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 101.26M | 118.11% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | 668.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.98B |
| Nordhealth AS | 3.04B |
| Photocure ASA | 1.74B |
| Vistin Pharma ASA | 1.09B |
| Omda AS | 1.05B |
| ArcticZymes Technologies ASA | 978.02M |
| Gentian Diagnostics ASA | 879.07M |
| Thor Medical ASA | 860.25M |